July 26, 2016


How Supplied


ZYMAR® (gatifloxacin ophthalmic solution) solution is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:

Aerobic Gram-Positive Bacteria:

Cornyebacterium propinquum*
Staphylococcus aureus

Staphylococcus epidermidis

Streptococcus mitis*

Streptococcus pneumoniae

Aerobic Gram-Negative Bacteria:

Haemophilus influenzae

* Efficacy for this organism was studied in fewer than 10 infections


The recommended dosage regimen for the treatment of bacterial conjunctivitis is:

Days 1 and 2: Instill one drop every two hours in the affected eye(s) while awake, up to 8 times daily.

Days 3 through 7: Instill one drop up to four times daily while awake.


ZYMAR® (gatifloxacin ophthalmic solution) (gatifloxacin ophthalmic solution) 0.3% is supplied sterile in a white, low density polyethylene (LDPE) bottle with a controlled dropper tip and a tan, high impact polystyrene (HIPS) cap in the following sizes:

2.5 mL in a 6 mL bottle- NDC 0023-9218-03

5 mL in an 10 mL bottle- NDC 0023-9218-05

Note: Store at 15°-25°C (59°-77°F). Protect from freezing.

Revised August 2004 ©2004 Allergan, Inc. Irvine, CA 92612, U.S.A. Licensed from: Kyorin Pharmaceuticals Co., Ltd. Marks owned by Allergan, Inc.
FDA Rev date: 6/20/2005

This monograph has been modified to include the generic and brand name in many instances.

Last reviewed on RxList: 8/14/2007

How Supplied

Zymar - User Reviews

Zymar User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Zymar sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Women's Health

Find out what women really need.